What are the FDA's minimum corneal thickness requirements for laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK)?

FDA Minimum Corneal Thickness for LASIK/PRK

The FDA does not specify an absolute minimum preoperative corneal thickness for LASIK or PRK procedures. However, the most recent clinical guidelines establish that for LASIK, a minimum residual stromal bed thickness of 250 μm is suggested as a safe threshold, though this does not guarantee prevention of ectasia 1.

Key Thickness Parameters for LASIK

The critical measurement is not the preoperative corneal thickness alone, but rather the residual stromal bed thickness after ablation:

• Minimum residual stromal bed: 250 μm (suggested safe threshold for LASIK) 1
• This calculation must account for: flap thickness + ablation depth subtracted from preoperative central corneal thickness
• No absolute value guarantees ectasia will not occur since the posterior cornea has weaker tensile strength than the anterior cornea 1

Percentage of Tissue Altered (PTA)

Beyond simple thickness measurements, the PTA ≥40% is associated with higher ectasia risk in eyes with normal preoperative topography 1:

PTA Formula: (Flap Thickness + Ablation Depth) / Preoperative Central Corneal Thickness

This metric provides a more comprehensive risk assessment than thickness alone.

PRK Considerations

PRK has no flap-related thickness requirements since it preserves more posterior stromal tissue by avoiding flap creation 1. This makes PRK advantageous for:

• Thinner corneas where LASIK residual bed would be inadequate
• Patients where maintaining maximum stromal integrity is prioritized
• Cases where the 250 μm residual bed cannot be safely achieved with LASIK

Research demonstrates that both LASIK and PRK can be safely performed in corneas thinner than 470 μm when the residual corneal bed exceeds 250 μm and preoperative topography is normal 2.

Critical Risk Factors Beyond Thickness

Abnormal topography is the most significant risk factor for postoperative ectasia 1, superseding thickness concerns. The evaluation must include:

• Corneal topography/tomography to exclude keratoconus or ectatic conditions
• Belin-Ambrosio enhanced ectasia display and similar indices
• Assessment of pachymetric distribution across the entire cornea
• Younger patient age and higher attempted corrections as additional risk factors 1

Clinical Decision Algorithm

1. Measure preoperative central corneal thickness via pachymetry
2. Calculate expected residual stromal bed: Preoperative CCT - (planned flap thickness + planned ablation depth)
3. If residual bed <250 μm for LASIK: Consider PRK instead
4. Calculate PTA: If ≥40% with normal topography, increased ectasia risk
5. Evaluate topography/tomography: Abnormal findings are contraindications regardless of thickness
6. Consider "insufficient corneal thickness for proposed ablation depth" as an absolute contraindication 1

Common Pitfalls

• Focusing solely on preoperative thickness without calculating residual bed thickness
• Ignoring PTA when residual bed appears adequate
• Proceeding with borderline thickness in presence of other risk factors (young age, high correction, suspicious topography)
• Failing to recognize that the 250 μm threshold is a suggestion, not a guarantee against ectasia 1

The evidence consistently demonstrates that multiple factors must be integrated rather than relying on a single FDA-mandated thickness cutoff, which does not exist. The 250 μm residual stromal bed for LASIK represents expert consensus from the 2023 American Academy of Ophthalmology Preferred Practice Pattern 1, not an FDA regulation.